Use of autologous serum eyedrops for the treatment of ocular surface disease: first US experience in a large population as an insurance-covered benefit

Arch Ophthalmol. 2012 Dec;130(12):1612-3. doi: 10.1001/archophthalmol.2012.1652.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Blood Transfusion, Autologous*
  • Eye Diseases / blood
  • Eye Diseases / therapy*
  • Female
  • Humans
  • Insurance Benefits
  • Male
  • Ophthalmic Solutions*
  • Retrospective Studies
  • United States

Substances

  • Ophthalmic Solutions